Trial intelligence / Profile preview

HDL Lipid Composition in Obese Metabolic Syndrome

NCT02851602Completed

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Nov 2013
Primary completion
Nov 2016
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Difference in the mass percentages of total phospholipids + sphingolipids compared with the total HDL mass. Started Nov 2013; status: completed.

Beyond the preview

Go deeper on NCT02851602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02851602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call